Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neuroendocrine Tumors 10Meningioma 6Neuroblastoma 5Carcinoid Tumor 5Medulloblastoma 3Paraganglioma 2Oncogenic osteomalacia 2Gastro-enteropancreatic neuroendocrine tumor 2Carcinoma, Neuroendocrine 2von Hippel-Lindau Disease 1Tumor Positron-Emission Tomography 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Prostatic Neoplasms 1Pinealoma 1Pheochromocytoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroectodermal Tumors, Primitive 1Neoplasms, Neuroepithelial 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ganglioneuroma 1Ganglioneuroblastoma 1Familial ependymoma 1

Interventions

gallium Ga 68 dotatate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Oncogenic osteomalacia × gallium Ga 68 dotatate × Clear all
NCT04689893 2021-01-05

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Peking Union Medical College Hospital

Phase 1 Unknown
50 enrolled

Oncogenic osteomalacia

NCT01524016 2017-04-07

68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled

Oncogenic osteomalacia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡